Microfluidic-assisted synthesis of mesoporous silica nanoparticles as drug carriers: characterization and biocompatibility studies
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Mesoporous Materials and Catalysis · Innovative Microfluidic and Catalytic Techniques Innovation · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (44)
Show source-provided references
1. Prasad M (2023) Advancements in targeted drug delivery systems: a review. Int J Adv Res Med Chemistry 5(1):9–1110.22271/27069567.2023.v5.i1a.430 ↗
2. Ding C, Tong L, Feng J, Fu J (2016) Recent advances in stimuli-responsive release function drug delivery systems for tumor treatment. Molecules 21(12):171510.3390/molecules21121715 ↗
3. Chamundeeswari M, Jeslin J, Verma ML (2019) Nanocarriers for drug delivery applications. Environ Chem Lett 17:849–86510.1007/s10311-018-00841-1 ↗
4. Lombardo D, Kiselev MA, Caccamo MT (2019) Smart nanoparticles for drug delivery application: development of versatile nanocarrier platforms in biotechnology and nanomedicine. J Nanomater 2019(1):26
5. Pérez-Herrero E, Fernández-Medarde A (2015) Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy. Eur J Pharm Biopharm 93:52–7910.1016/j.ejpb.2015.03.018 ↗
6. Beretta GL, Cavalieri F (2016) Engineering nanomedicines to overcome multidrug resistance in cancer therapy. Curr Med Chem 23(1):3–2210.2174/0929867322666151006094559 ↗
7. Bozdağ Pehlivan S (2013) Nanotechnology-based drug delivery systems for targeting, imaging and diagnosis of neurodegenerative diseases. Pharm Res 30:2499–251110.1007/s11095-013-1156-7 ↗
8. Jafari S, Derakhshankhah H, Alaei L, Fattahi A, Varnamkhasti BS, Saboury AA (2019) Mesoporous silica nanoparticles for therapeutic/diagnostic applications. Biomed Pharmacother 109:1100–111110.1016/j.biopha.2018.10.167 ↗
9. Ghaferi M, KoohiMoftakhariEsfahani M, Raza A, Al Harthi S, EbrahimiShahmabadi H, Alavi SE (2021) Mesoporous silica nanoparticles: synthesis methods and their therapeutic use-recent advances. J Drug Target 29(2):131–15410.1080/1061186X.2020.1812614 ↗
10. Manzano M, Vallet-Regí M (2020) Mesoporous silica nanoparticles for drug delivery. Adv Func Mater 30(2):190263410.1002/adfm.201902634 ↗
11. Vazquez NI, Gonzalez Z, Ferrari B, Castro Y (2017) Synthesis of mesoporous silica nanoparticles by sol–gel as nanocontainer for future drug delivery applications. Boletín de la Sociedad Española de Cerámica y Vidrio 56(3):139–14510.1016/j.bsecv.2017.03.002 ↗
12. Li Z, Zhang Y, Feng N (2019) Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery. Expert Opin Drug Deliv 16(3):219–23710.1080/17425247.2019.1575806 ↗
13. Ahmadi E, Dehghannejad N, Hashemikia S, Ghasemnejad M, Tabebordbar H (2014) Synthesis and surface modification of mesoporous silica nanoparticles and its application as carriers for sustained drug delivery. Drug Delivery 21(3):164–17210.3109/10717544.2013.838715 ↗
14. Wang Y, Zhao Q, Han N, Bai L, Li J, Liu J, Che E, Hu L, Zhang Q, Jiang T, Wang S (2015) Mesoporous silica nanoparticles in drug delivery and biomedical applications. Nanomed: Nanotechnol Biol Med 11(2):313–32710.1016/j.nano.2014.09.014 ↗
15. Park JI, Saffari A, Kumar S, Günther A, Kumacheva E (2010) Microfluidic synthesis of polymer and inorganic particulate materials. Annu Rev Mater Res 40:415–44310.1146/annurev-matsci-070909-104514 ↗
16. Hao N, Nie Y, Zhang JX (2018) Microfluidic synthesis of functional inorganic micro-/nanoparticles and applications in biomedical engineering. Int Mater Rev 63(8):461–48710.1080/09506608.2018.1434452 ↗
17. Kang KK, Lee B, Lee CS (2019) Recent progress in the synthesis of inorganic particulate materials using microfluidics. J Taiwan Inst Chem Eng 98:2–1910.1016/j.jtice.2018.08.027 ↗
18. Khizar S, Zine N, Errachid A, Jaffrezic-Renault N, Elaissari A (2022) Microfluidic-based nanoparticle synthesis and their potential applications. Electrophoresis 43(7–8):819–83810.1002/elps.202100242 ↗
19. Długosz O, Banach M (2020) Inorganic nanoparticle synthesis in flow reactors–applications and future directions. React Chem Eng 5(9):1619–164110.1039/D0RE00188K ↗
20. Makgwane PR, Ray SS (2014) Synthesis of nanomaterials by continuous-flow microfluidics: a review. J Nanosci Nanotechnol 14(2):1338–136310.1166/jnn.2014.9129 ↗
21. Illath K, Kar S, Gupta P, Shinde A, Wankhar S, Tseng FG, Lim KT, Nagai M, Santra TS (2022) Microfluidic nanomaterials: from synthesis to biomedical applications. Biomaterials 280:12124710.1016/j.biomaterials.2021.121247 ↗
22. Hao N, Nie Y, Zhang JX (2019) Microfluidics for silica biomaterials synthesis: opportunities and challenges. Biomater Sci 7(6):2218–224010.1039/C9BM00238C ↗
23. Shi H, Nie K, Dong B, Long M, Xu H, Liu Z (2019) Recent progress of microfluidic reactors for biomedical applications. Chem Eng J 361:635–65010.1016/j.cej.2018.12.104 ↗
24. Zhang L, Chen Q, Ma Y, Sun J (2019) Microfluidic methods for fabrication and engineering of nanoparticle drug delivery systems. ACS Appl Bio Mater 3(1):107–12010.1021/acsabm.9b00853 ↗
25. Khan SA, Günther A, Schmidt MA, Jensen KF (2004) Microfluidic synthesis of colloidal silica. Langmuir 20(20):8604–861110.1021/la0499012 ↗
26. Dash S, Murthy PN, Nath L, Chowdhury P (2010) Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm 67(3):217–223
27. Saharkhiz S, Nasri N, Dini G, Yousefnia S (2023) Development of a new smart theranostic anti-PSMA-aptamer conjugated cationic-lipid coated mesoporous silica platform for targeted delivery of paclitaxel and CdSe/ZnS quantum dots to LNCaP cell line. J Drug Deliv Sci Technol 88:10496410.1016/j.jddst.2023.104964 ↗
28. Zhou YY, Li XX, Chen ZX (2012) Rapid synthesis of well-ordered mesoporous silica from sodium silicate. Powder Technol 226:239–24510.1016/j.powtec.2012.04.054 ↗
29. Ghahfarokhi MR, Dini G, Movahedi B (2022) Fabrication of chitosan-coated mesoporous silica nanoparticles bearing rosuvastatin as a drug delivery system. Curr Drug Deliv 19(1):64–7310.2174/1567201818666210609165630 ↗
30. Liu R, Wang CA (2015) Synthesis of hollow mesoporous silica spheres with radially aligned mesochannels and tunable textural properties. Ceram Int 41(1):1101–110610.1016/j.ceramint.2014.09.035 ↗
31. Abburi A, Ali M, Moriya PV (2020) Synthesis of mesoporous silica nanoparticles from waste hexafluorosilicic acid of fertilizer industry. J Market Res 9(4):8074–8080
32. Lengert EV, Trushina DB, Soldatov M, Ermakov AV (2022) Microfluidic synthesis and analysis of bioinspired structures based on CaCO3 for potential applications as drug delivery carriers. Pharmaceutics 14(1):13910.3390/pharmaceutics14010139 ↗
33. Popa ML, Preda MD, Neacșu IA, Grumezescu AM, Ginghină O (2023) Traditional vs. microfluidic synthesis of ZnO nanoparticles. Int J Mol Sci 24(3):187510.3390/ijms24031875 ↗
34. Nasri N, Saharkhiz S, Dini G, Yousefnia S (2023) Thermo-and pH-responsive targeted lipid-coated mesoporous nano silica platform for dual delivery of paclitaxel and gemcitabine to overcome HER2-positive breast cancer. Int J Pharm 648:12360610.1016/j.ijpharm.2023.123606 ↗
35. Karimzade MM, Rashidi L, Ganji F, Ahmadi M, Tahmasebi Enferadi S (2014) Application of mesoporous silica nanoparticles as a drug delivery system for rivastigmine hydrogen tartrate. Iran J Biomed Eng 8(4):385–398
36. Day CM, Sweetman MJ, Song Y, Plush SE, Garg S (2021) Functionalized mesoporous silica nanoparticles as delivery systems for doxorubicin: drug loading and release. Appl Sci 11(13):612110.3390/app11136121 ↗
37. Gu J, Su S, Zhu M, Li Y, Zhao W, Duan Y, Shi J (2012) Targeted doxorubicin delivery to liver cancer cells by PEGylated mesoporous silica nanoparticles with a pH-dependent release profile. Microporous Mesoporous Mater 161:160–16710.1016/j.micromeso.2012.05.035 ↗
38. Mishra AK, Pandey H, Agarwal V, Ramteke PW, Pandey AC (2014) Nanoengineered mesoporous silica nanoparticles for smart delivery of doxorubicin. J Nanopart Res 16:1–1010.1007/s11051-014-2515-y ↗
39. Sikora T, Morawska K, Lisowski W, Rytel P, Dylong A (2022) Application of optical methods for determination of concentration of doxorubicin in blood and plasma. Pharmaceuticals 15(2):11210.3390/ph15020112 ↗
40. Kong T, Hao L, Wei Y, Cai X, Zhu B (2018) Doxorubicin conjugated carbon dots as a drug delivery system for human breast cancer therapy. Cell Prolif 51(5):e1248810.1111/cpr.12488 ↗
41. Yameen B, Choi WI, Vilos C, Swami A, Shi J, Farokhzad OC (2014) Insight into nanoparticle cellular uptake and intracellular targeting. J Control Release 190:485–49910.1016/j.jconrel.2014.06.038 ↗
42. Duo Y, Li Y, Chen C, Liu B, Wang X, Zeng X, Chen H (2017) DOX-loaded pH-sensitive mesoporous silica nanoparticles coated with PDA and PEG induce pro-death autophagy in breast cancer. RSC Adv 7(63):39641–3965010.1039/C7RA05135B ↗
43. Popat A, Liu J, Lu GQM, Qiao SZ (2012) A pH-responsive drug delivery system based on chitosan coated mesoporous silica nanoparticles. J Mater Chem 22(22):11173–1117810.1039/c2jm30501a ↗
44. Qu F, Zhu G, Huang S, Li S, Sun J, Zhang D, Qiu S (2006) Controlled release of captopril by regulating the pore size and morphology of ordered mesoporous silica. Microporous Mesoporous Mater 92(1–3):1–910.1016/j.micromeso.2005.12.004 ↗